Inventor · disambiguated record
Michael J. Lenardo
Also filed as: LENARDO MICHAEL · LENARDO MICHAEL J
14 granted patents·6 pending applications·392 citations·filing 1993–2024
92Inventor score
Top patents by PatentIndex Score
20 records- 0191US6410516B1Nuclear factors associated with transcriptional regulationHARVARD COLLEGE·Filed 1995·Granted Jun 25, 2002·167 cites·203 claims
- 0287US6150090ANuclear factors associated with transcriptional regulationMASSACHUSETTS INST TECHNOLOGY·Filed 1995·Granted Nov 21, 2000·69 cites·24 claims
- 0383US7148061B2Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and functionUS HEALTH·Filed 2001·Granted Dec 12, 2006·13 cites·25 claims
- 0483US5804374ANuclear factors associates with transcriptional regulationMASSACHUSETTS INSTI TECHNOLOGY·Filed 1995·Granted Sep 8, 1998·82 cites·5 claims
- 0580US12168802B2Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan diseaseUS HEALTH·Filed 2023·Granted Dec 17, 2024·1 cites·10 claims
- 0675US7838645B2Function of autophagy genes in cell deathUNIV MARYLAND·Filed 2005·Granted Nov 23, 2010·2 cites·2 claims
- 0774US6083503AInterleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejectionUS HEALTH·Filed 1993·Granted Jul 4, 2000·25 cites·14 claims
- 0868US2025207198A1Methods of diagnosing and treating cd55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (chaple), a newly identified orphan diseaseUS HEALTH·Filed 2024·Application pending·0 cites
- 0958US2006063709A1Nuclear factors associated with transcriptional regulationBALTIMORE DAVID·Filed 2002·Application pending·0 cites
- 1055US2004214757A1Nuclear factors associated with transcriptional regulationFiled 2002·Application pending·0 cites
- 1154US12458683B2Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2020·Granted Nov 4, 2025·0 cites·9 claims
- 1252US5935575AInterleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disordersUS HEALTH·Filed 1994·Granted Aug 10, 1999·13 cites·17 claims
- 1351US5989546AInterleukin-2 stimulated T lymphocyte cell death for the treatment of allergic responsesUS HEALTH·Filed 1995·Granted Nov 23, 1999·11 cites·7 claims
- 1449US9051392B2Inhibitors of pre-ligand assembly doman and function of the tumor necrosis factor receptor familyLENARDO MICHAEL J·Filed 2006·Granted Jun 9, 2015·0 cites·13 claims
- 1549US2019256915A1Methods of diagnosing and treating cd55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (chaple), a newly identified orphan diseaseUS HEALTH·Filed 2017·Application pending·0 cites
- 1643US10759838B2Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of useUS HEALTH·Filed 2016·Granted Sep 1, 2020·0 cites·6 claims
- 1742US6312648B1Applicator systemUS HEALTH·Filed 1998·Granted Nov 6, 2001·9 cites·19 claims
- 1842US2008019909A1Modulation of Programmed NecrosisCHAN FRANCIS KA-MING·Filed 2004·Application pending·0 cites
- 1940US2010041596A1Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor ReceptorsLENARDO MICHAEL·Filed 2006·Application pending·0 cites
- 2026US7041503B2Modified myelin basic protein moleculesALEXION PHARMA INC·Filed 1995·Granted May 9, 2006·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →